Skip to content

Organogenesis Inc

ORGO

Latest QuantConomy context for ORGO: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.

Asset class
stock
Primary venue
NASDAQ
Recent signals
3
SEC filings
20
Asset profile

Organogenesis Inc

QuantConomy has a structured record for ORGO. More descriptive asset metadata will appear here when the platform record includes it.

Symbol
ORGO
Name
Organogenesis Inc
Coverage
3 market/data records
Sources
alphavantage alpaca fmp sec nasdaq
Latest signal rows

Recent signals for ORGO

Scored rows are pulled from the same signal API used by the digests.

Signal Direction Score Observed Reason
earnings release
neutral
40
Feb 26, 12:00 AM ORGO filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-26. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read).
executive change
neutral
85
Jun 16, 08:40 PM ORGO filed 8-K: Director or Officer Changes, Shareholder Vote Results - 1 material event - [very strong neutral signal]
earnings
neutral
75
May 7, 08:16 PM ORGO filed 8-K: Earnings Release - 1 material event - [strong neutral signal]

EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).

Market coverage

Market Exchange Source Asset record
ORGO NASDAQ alphavantage Organogenesis Holdings Inc - Class A
ORGO NASDAQ alpaca Organogenesis Holdings Inc. Class A Common Stock
ORGO NASDAQ fmp Organogenesis Holdings Inc.

Recent insider transactions

Buys, last 90d
0
Sells, last 90d
0
Rows
20
Date Insider Role Type Shares Price Value Filing
Mar 9, 2026 Driscoll Michael Joseph Insider purchase 10,000 $2.67 $26,688 4 on EDGAR
Mar 9, 2026 Leibowitz Arthur S Insider purchase 5,000 $2.68 $13,405 4 on EDGAR
Mar 1, 2026 Cavorsi Robert Vice President, Strategy other 700 $3.21 $2,247 4 on EDGAR
Feb 18, 2026 Leibowitz Arthur S Insider grant 48,828 $0.00 $0 4 on EDGAR
Feb 18, 2026 Quintero Gilberto Insider grant 48,828 $0.00 $0 4 on EDGAR
Feb 18, 2026 Gillheeney Gary S. President and CEO grant 890,625 $0.00 $0 4 on EDGAR
Feb 18, 2026 Freedman Lori Chief Admin. and Legal Officer grant 203,125 $0.00 $0 4 on EDGAR
Feb 18, 2026 Driscoll Michael Joseph Insider grant 48,828 $0.00 $0 4 on EDGAR
Feb 18, 2026 Francisco David Chief Financial Officer grant 195,312 $0.00 $0 4 on EDGAR
Feb 18, 2026 Bilbo Patrick Chief Operating Officer grant 210,937 $0.00 $0 4 on EDGAR
Feb 18, 2026 Giacomin Jon L Insider grant 48,828 $0.00 $0 4 on EDGAR
Feb 18, 2026 Montecalvo Antonio S. Vice President, Health Policy grant 40,625 $0.00 $0 4 on EDGAR
Feb 18, 2026 Duraibabu Prathyusha Insider grant 48,828 $0.00 $0 4 on EDGAR
Feb 18, 2026 Cavorsi Robert Vice President, Strategy grant 93,750 $0.00 $0 4 on EDGAR
Feb 18, 2026 Korfin Michele Ilene Insider grant 48,828 $0.00 $0 4 on EDGAR
Feb 18, 2026 Grow Brian Chief Commercial Officer grant 234,375 $0.00 $0 4 on EDGAR
McGuire Patrick Chief Accounting Officer 3 on EDGAR
Feb 18, 2026 Lustig Garrett Insider grant 48,828 $0.00 $0 4 on EDGAR
Nov 24, 2025 NUSSDORF GLENN H Insider sale 100,000 $5.34 $534,000 4 on EDGAR
Jan 10, 2025 Grow Brian Chief Commercial Officer exercise 958 $1.24 $1,188 4 on EDGAR

Source: SEC filings via QuantConomy. Not investment advice.

Get the data

Query ORGO context like a database.

These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.

No spam, no noise. Just the launch and the occasional preview.

More: All insider trades · How to read a Form 4 · API access